Ledger.Open graph →
SEC Form D · filed November 20, 2018

Amylyx Pharmaceuticals, Inc

Offering
$13.0M
Sold
$13.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Felix Von Coerper · Cambridge, MADirectorJustin Klee · Cambridge, MAExec · DirectorStephen D. Chubb · Cambridge, MADirectorGeorge Milne · Cambridge, MADirectorJoshua Cohen · Cambridge, MAExec · DirectorIsaac Cheng · Cambridge, MADirectorPeter B. Finn · Boston, MAExecWalter Gilbert · Cambridge, MADirectorDavid B. Carrig · Dallas, TXDirectorJonathan J. Desimone · Boston, MAExec · DirectorSriram N. Viswanathan · Grand Cayman, Cayman IslandsDirectorEric M. Siegal · CHICAGO, ILExecNolan Chicoine · Calgary, Alberta, CanadaDirectorJames F. Kellogg Iii · Boston, MADirectorChristopher F. Linneman · Boston, MAExec · Directornull Platinum Group · Calabasas, CADirectorDaniel M. Rosenbloom · CHICAGO, ILExecMikhail Plam · Louisville, CODirectorDavid C. Barker · Louisville, COExec · DirectorNiles C. Utlaut · Louisville, COExec · DirectorCorporate Director Gpe Viii Investments Manager Limited · Nicosia, G4DirectorJohn F. Warnken-Brill · San Francisco, CADirectorDavid F. Flannery · San Francisco, CADirectorBasil Williams · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗